Trial Search Results

The Impact of Pediatric Skin Disorders: The "Big" Study

This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Northwestern University

Collaborator: Pediatric Dermatology Research Alliancce

Stanford Investigator(s):

Eligibility


Inclusion Criteria:

   - Subjects must be aged 8-17 years of age

   - Subject must be diagnosed with a chronic skin disease deemed to be severe enough
   and/or in a visible location that could be stigmatizing as determined by the study
   doctor

   - Subject and parent must both be English speaking with at least one parent/guardian who
   will complete the questionnaires

   - Subject and Parent/Guardian must be able to complete the relevant questionnaires

Exclusion Criteria:

   - Children under 8 years of age

   - Children with developmental delay and/or a behavioral disorder that would preclude
   participation in form completion

   - Children with a non-cutaneous disorder that is considered by the Study doctor to be
   stigmatizing

Ages Eligible for Study

8 Years - 17 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Pediatric Dermatology Study
650-723-0636
Not Recruiting